MedWatch

Medtronic to spin off patient-monitoring, lung-treatment units

Within the next year to 18 months, the medtech company is expecting to strengthen its focus on its more profitable efforts.

Photo: Jim Mone/AP/Ritzau Scanpix

Medical devicemaker Medtronic Plc will spin off its patient-monitoring and respiratory-intervention businesses, another move by a major health-care manufacturer to narrow focus on its most lucrative activities.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs